Feasibility of treating irradiated bone with intramedullary delivered autologous mesenchymal stem cells

J Biomed Biotechnol. 2011:2011:560257. doi: 10.1155/2011/560257. Epub 2011 Aug 29.

Abstract

Background: We aimed to explore (i) the short-term retention of intramedullary implanted mesenchymal stem cells BMSCs and (ii) their impact on the bone blood flow and metabolism in a rat model of hindlimb irradiation.

Methods: Three months after 30 Gy irradiation, fourteen animals were referred into 2 groups: a sham-operated group (n = 6) and a treated group (n = 8) in which ¹¹¹In-labelled BMSCs (2 × 10⁶ cells) were injected in irradiated tibias. Bone blood flow and metabolism were assessed by serial (99m)Tc-HDP scintigraphy and 1-wk cell retention by recordings of (99m)Tc/¹¹¹In activities.

Results: The amount of intramedullary implanted BMSCs was of 70% at 2 H, 40% at 48 H, and 38% at 168 H. Bone blood flow and bone metabolism were significantly increased during the first week after cell transplantation, but these effects were found to reduce at 2-mo followup. Conclusion. Short-term cell retention produced concomitant enhancement in irradiated bone blood flow and metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD / metabolism
  • Bone Marrow Cells / chemistry
  • Bone Marrow Cells / cytology*
  • Bone Marrow Cells / metabolism
  • Feasibility Studies
  • Gamma Rays
  • Indium
  • Mesenchymal Stem Cell Transplantation*
  • Mesenchymal Stem Cells / chemistry
  • Mesenchymal Stem Cells / cytology*
  • Osteoblasts / chemistry
  • Osteoblasts / metabolism
  • Radiotherapy
  • Rats
  • Rats, Wistar
  • Regional Blood Flow
  • Statistics, Nonparametric
  • Tibia / blood supply
  • Tibia / metabolism
  • Tibia / radiation effects
  • Tibia / surgery*
  • Tomography, Emission-Computed, Single-Photon
  • Transplantation, Autologous

Substances

  • Antigens, CD
  • Indium